US Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022



The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2010-2016, the US generic drug market grew at a CAGR of more than 13% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

Generic Drug Market Report

The report entitled “US Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the United States. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the US generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the US generic drug market in any form.

US Generic Drug Market

Key Questions Answered in This Report:

  • Historical, current and future sales trends in the US generic drug market?
  • Historical, current and future prescription trends in the US generic drug market?
  • Performance of the US generic drug market compared to the US pharmaceutical market?
  • Performance of the US generic drug market compared to other major generic drug markets?
  • Structure of the US generic drug market?
  • Competitive landscape in the US generic drug market?
  • Top US generic drug manufacturers and their market shares?
  • Distribution of generic drugs in the US?
  • Top US generic drug distributors and their market shares?
  • Most prescribed generic drugs in the US?
  • Pricing analysis of generic drugs?
  • Value chain analysis of generic drugs in the US?
  • Regulations in the US generic drug market?
  • Manufacturing process of generic drugs?
  • Machinery and raw material requirements for manufacturing generic drugs?
  • Key success and risk factors in the US generic drug market?

1 Preface
2 Research Methodology and Market Definitions
3 Executive Summary
4 US Generic Drug Market - Introduction

    4.1 What are Generic Drugs?
    4.2 Unbranded and Branded Generics
    4.3 Authorized Generics
    4.4 Commoditized and Specialty Generics
5 Why is the US Generic Drug Market so Lucrative
    5.1 Patent Expiry of Blockbuster Drugs
    5.2 Significant Price Differential between Generics and Innovator Drugs
    5.3 Savings for the Government and Third Party Payers
    5.4 Incentives for Dispensing and Prescribing Generic Drugs
    5.5 Reimbursement and Lower Copayments
    5.6 Biosimilars
6 Global Generic Drug Market
    6.1 Market Performance
        6.1.1     Volume Trends
        6.1.2    Value Trends
    6.2 Market Breakup by Country
    6.3 Market Forecast
    6.4 Most Prescribed Generic and Branded Drugs
7 US Generic Drug Market
    7.1 US Pharmaceutical Market Performance
        7.1.1    Volume Trends
        7.1.2    Value Trends
        7.1.3    Market Breakup by Type
        7.1.4    Market Forecast
    7.2 US Generic Drug Market Performance
        7.2.1    Volume Trends
        7.2.2    Value Trends
        7.2.3    Market Breakup by Segment
         7.2.4    Market Forecast
8 SWOT Analysis
    8.1 Strengths
    8.2 Weaknesses
    8.3 Opportunities
    8.4 Threats
9 US Generic Drug Market - Value Chain Analysis
    9.1 Research and Development
    9.2 Manufacturing
    9.3 Marketing and Distribution
10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
11 Porter’s Five Forces Analysis

    11.1 Overview
    11.2 Bargaining Power of Buyers
    11.3 Bargaining Power of Suppliers
    11.4 Degree of Rivalry
    11.5 Threat of New Entrants
     11.6 Threat of Substitutes
12 US Generic Drug Market- Competitive Landscape
    12.1 US Generic Drug Market - Competitive Structure
    12.2 US Generic Drug Market - Sales Breakup of Key Players
    12.3 US Generic Drug Market - Volume Breakup of Key Players
    12.4 US Generic Drug Market - Most Prescribed Generic Drugs
    12.5 US Generic Drug Market - Market Breakup by Distribution
    12.6 US Generic Drug Market - Pricing Dynamics
13 Regulations in the US Generic Drug Industry
    13.1 Overview of Pharmaceutical Regulations
    13.2 Drug Applications
    13.3 Patents and Market Exclusivity
    13.4 Regulatory Requirements for Generic Drugs
    13.5 The Hatch-Waxman Act
    13.6 Certifications
    13.7 Other Important Considerations
14 US Generic Drug Market: Key Success Factors
15 US Generic Drug Market: Road Blocks
16 Requirements for Setting Up a Generic Drug Manufacturing Plant

     16.1 Manufacturing Process
     16.2 Raw Material Requirements
     16.3 Raw Materials Pictures
     16.4 Land and Construction Requirements 
     16.5 Machinery and Infrastructure Requirements
     16.6 Machinery Pictures
     16.7 Plant Layout
     16.8 Packaging Requirements 
     16.9 Utility Requirements 
    16.10 Manpower Requirements
17 US Generic Drug Market - Key Company Profiles
    17.1 Teva
    17.2 Mylan
    17.3 Actavis
    17.4 Sandoz
    17.5 Sun Pharma
    17.6 Par Pharmaceuticals
    17.7 Endo Pharmaceuticals
    17.8 Lupin Pharmaceuticals
    17.9 Dr Reddy’s
    17.10 Hospira    
 

List of Figures

Figure 4-1: Structure of the Pharmaceutical Industry
Figure 4-2: Classification of Generic Drugs
Figure 5-1: US: Patent Expiry Exposure (in Billion US$), 2009-2018
Figure 5-2: US: Savings from Generic Drugs (in Billion US$), 2005-2016
Figure 6-1: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2016
Figure 6-2: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2010-2016
Figure 6-3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2016
Figure 6-4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2016
Figure 6-5: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2017-2022
Figure 6-6: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2017-2022
Figure 7-1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2016
Figure 7-2: US: Pharmaceutical Market: Sales Value (in Billion US$), 2010-2016
Figure 7-3: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2017-2022
Figure 7-4: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2017-2022
Figure 7-5: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 and 2016
Figure 7-6: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 and 2016
Figure 7-7: US: Generic Drug Market: Sales Volume (in Million Prescriptions), 2010-2016
Figure 7-8: US: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2017-2022
Figure 7-9: US: Generic Drug Market: Sales Value (in Billion US$), 2010-2016
Figure 7-10: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2017-2022
Figure 7-11: US: Generic Drug Market: Market Breakup by Segment (in %), 2010-2016
Figure 8-1: US: Generic Drug Market: SWOT Analysis
Figure 9-1: US: Generic Drug Market: Value Chain Analysis
Figure 10-1: US: Generic Drug Market: Pricing Mechanism and Profit Margins at the Various Levels of the Supply Chain
Figure 11-1: US: Generic Drug Market: Porter's Five Forces Analysis
Figure 12-1: US: Generic Drug Market: Sales Share of Top Players (in %), 2016
Figure 12-2: US: Generic Drug Market: Volume Share of Top Players (in %), 2016
Figure 12-3: US: Generic Drug Market: Volume Share by Distribution (in %), 2016
Figure 12-4: US: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors
Figure 16-1: US: Generic Drug Market: Detailed Process Flow
Figure 16-2: US: Generic Drug Market: Raw Material Requirements
Figure 16-3: US: Generic Drug Market: Plant Layout
Figure 16-4: US: Generic Drug Market: Packaging Requirements

 
List of Tables

Table 4-1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 4-2: US: Expenses of Generic and Branded Drug Manufacturers (in %)
Table 5-1:  Sales Volume and Growth in Major Markets, 2016
Table 5-2: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2016
Table 5-3: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2016
Table 7-1: US: generic Drug Market: Sales Performance of Top Players (in Billion US$), 2016
Table 7-2: US: Generic Drug Market: Volume Performance of Top Players (in Billion Units), 2016
Table 7-3: US: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2016
Table 9-1: US: Overview of Pharmaceutical Regulations
Table 16-1: US: Generic Drug Market: Land and Construction Requirements
Table 16-2: US: Generic Drug Market: Machinery and Infrastructure Requirements
Table 16-3: US: Generic Drug Market: Utility Requirements
Table 16-4: US: Generic Drug Market: Manpower Requirements


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2016-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2016-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2016-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2016-2021)

The new report from IMARC group entitled ‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2008-2021)’ maps out a comprehensive analysis o...


Canada Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The report entitled “Canada Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool ...


Japan Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The report entitled “Japan Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to...